In the Treatment of Allergic Rhinitis
There Are Many Options...

treatment

ASTEPRO 0.15%—the Earlier the Better1,2

earlier

*In 2 placebo-controlled SAR studies (N=1143), ASTEPRO 0.15% (2 sprays per nostril) relieved rhinitis symptoms as early as 30 to 45 minutes, and the effect remained durable over the 4-hour assessment period.
† When prescribed once daily for SAR; calculation based on 2 sprays per nostril once daily.

Click here to learn about ASTEPRO 0.15%’s proven efficacy and other important information

Click here to download the Prescribing Information

 

e-Newsletter

Coming soon! Sign up for our healthcare professionals email series
 

View FAQs

See Frequently Asked Questions about ASTEPRO 0.15%
 

Go

e-Sampling

Sign up electronically to order samples of ASTEPRO 0.15%
 

Go

 

Indication

ASTEPRO® (azelastine HCl) Nasal Spray 0.15% is indicated for the relief of the symptoms of seasonal and perennial allergic rhinitis in patients 12 years of age and older.

Important Risk Information

  • Avoid engaging in hazardous occupations requiring complete mental alertness when taking ASTEPRO Nasal Spray 0.15%
  • Avoid concurrent use of alcohol or other central nervous system depressants with ASTEPRO Nasal Spray 0.15%
  • In clinical studies, the most commonly reported adverse reactions, when dosed at 2 sprays per nostril once or twice daily, respectively, included bitter taste (4%, 6%), nasal discomfort (4%, 3%), epistaxis (2%, 1%), and sneezing (1%, 2%)
  • Pregnancy Category C: Based on animal data, may cause fetal harm
    Please see full Prescribing Information
    You are encouraged to report negative side effects of prescription drugs to the FDA.
    Visit www.fda.gov/medwatch, or call 1‐800‐FDA‐1088